iCo Therapeutics Inc. Agrees to a Business Combination with Satellos Bioscience Inc.

Ontario Industry Updates
Written By Maura Campbell
Satellos-bioscience.png

iCo Therapeutics Inc. and Satellos Bioscience Inc., announced business combination of iCo and Satellos. The parties expect to complete an amalgamation of iCo and Satellos, with the resulting entity named "Satellos Bioscience Inc." operating in the life sciences industry.

Maura Campbell
Previous

OBIO’s Women in the Business of Health Science Bootcamp Participants are Ready to Enter the Health Science Industry
Next

Canada-Israel Cardiovascular Innovation Forum Innovation Competition